A financial report detailing Jeffrey Epstein's biotech investments as of April 2, 2014, showing a total unrealized gain of $906,910 excluding Ariad Pharmaceuticals.
documents/vol00010-efta01461557-pdf.pdf
{"key_people":["Jeffrey Epstein"],"document_date":"2014-04-02","document_type":"tabular","document_subtype":"financial report","key_organizations":["Sangamo Biosciences","Biogen","Foundation Medicine","Gilead Sciences Inc","Ariad Pharmaceuticals"]}